Literature, news and videos pertinent to
The Yi-Ting Wei Advocacy Program

National Lung Screening Trial Results Highlight Importance of Lifelong Follow-up
By The ASCO Post Staff
October 10, 2022 - Supplement: Conference Highlights IASLC 2022

Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)CMS.gov Centers for Medicare & Medicaid Services

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT)ClinicalTrials.gov

powered by Surfing Waves

Yi-Ting Wei


The Yi-Ting Wei Advocacy Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

We also accept PayPal
paypal.me/ICANadvocacy


Guidestar Platinum Seal of Transparency 2021


Federal Tax I.D.: EIN 86-0818253